Aveanna Healthcare Holdings Inc AVAH.OQ reported quarterly adjusted earnings of 5 cents per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -2 cents. The mean expectation of eight analysts for the quarter was for breakeven results per share. Wall Street expected results to range from -1 cents to 1 cents per share.
Revenue rose 8.6% to $519.87 million from a year ago; analysts expected $499.61 million.
Aveanna Healthcare Holdings Inc's reported EPS for the quarter was 14 cents.
The company reported quarterly net income of $29.18 million.
Aveanna Healthcare Holdings Inc shares had fallen by 18.2% this quarter.
FORECAST CHANGES
In the last 30 days, one analyst negatively revised an earnings estimate
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 5 "hold" and 2 "sell" or "strong sell."
The average consensus recommendation for the healthcare facilities & services peer group is also "hold"
Wall Street's median 12-month price target for Aveanna Healthcare Holdings Inc is $5.25
This summary was machine generated from LSEG data March 13 at 01:30 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Dec. 31 2024 | 0.00 | 0.05 | Beat |
Sep. 30 2024 | -0.01 | 0.02 | Beat |
Jun. 30 2024 | -0.02 | 0.01 | Beat |
Mar. 31 2024 | -0.05 | -0.03 | Beat |
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.